Consistently, our use of the Human Protein Atlas [45] to assess correlation between ITGA3 mRNA expression level and patient survival revealed that while high ITGA3 expression is prognostic of poor outcomes in head and neck SCC, pancreatic cancer, and lung cancer, low ITGA3 expression is correlated with poor survival in colon cancer (Figure S1). The gene discussed is ITGA3; the disease is pancreatic neoplasm.